(+)-catechin multiple interactions ISO RGD:730866 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of RGS5 mRNA CTD PMID:24763279 1,2,4-trimethylbenzene increases expression EXP 6480464 pseudocumene results in increased expression of RGS5 protein CTD PMID:17337753 1,2-dimethylhydrazine increases expression ISO RGD:730867 6480464 1, 2-Dimethylhydrazine results in increased expression of RGS5 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of RGS5 mRNA CTD PMID:25380136 17alpha-ethynylestradiol increases expression ISO RGD:730867 6480464 Ethinyl Estradiol results in increased expression of RGS5 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:730867 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of RGS5 mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression ISO RGD:730867 6480464 Ethinyl Estradiol affects the expression of RGS5 mRNA CTD PMID:17555576 17beta-estradiol multiple interactions ISO RGD:730866 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of RGS5 mRNA CTD PMID:17404688 17beta-estradiol decreases expression ISO RGD:730867 6480464 Estradiol results in decreased expression of RGS5 mRNA CTD PMID:19484750 17beta-estradiol decreases expression ISO RGD:730866 6480464 Estradiol results in decreased expression of RGS5 mRNA CTD PMID:21795739 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:730867 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of RGS5 mRNA more ... CTD PMID:16214954 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of RGS5 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:730867 6480464 Tetrachlorodibenzodioxin results in decreased expression of RGS5 mRNA CTD PMID:16891777 , PMID:18796159 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of RGS5 mRNA CTD PMID:21346803 3,4-methylenedioxymethamphetamine increases expression ISO RGD:730867 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of RGS5 mRNA CTD PMID:20188158 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of RGS5 mRNA CTD PMID:28522335 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of RGS5 mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol increases expression ISO RGD:730867 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of RGS5 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression ISO RGD:730867 6480464 Fenretinide results in increased expression of RGS5 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide increases expression ISO RGD:730866 6480464 Fenretinide results in increased expression of RGS5 mRNA CTD PMID:16671099 5-fluorouracil decreases expression ISO RGD:730867 6480464 Fluorouracil results in decreased expression of RGS5 mRNA CTD PMID:18157009 5-fluorouracil multiple interactions ISO RGD:730867 6480464 IFNA1 protein promotes the reaction [Fluorouracil results in decreased expression of RGS5 mRNA] CTD PMID:18157009 Actein increases expression EXP 6480464 actein results in increased expression of RGS5 protein CTD PMID:29969672 all-trans-retinoic acid increases expression ISO RGD:730866 6480464 Tretinoin results in increased expression of RGS5 mRNA CTD PMID:21934132 , PMID:23724009 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of RGS5 mRNA CTD PMID:10098858 , PMID:30779732 antirheumatic drug increases expression ISO RGD:730866 6480464 Antirheumatic Agents results in increased expression of RGS5 mRNA CTD PMID:24449571 arsane affects methylation ISO RGD:730866 6480464 Arsenic affects the methylation of RGS5 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:730866 6480464 Arsenic affects the methylation of RGS5 gene CTD PMID:25304211 avobenzone decreases expression ISO RGD:730866 6480464 avobenzone results in decreased expression of RGS5 mRNA CTD PMID:31016361 benzo[a]pyrene affects methylation ISO RGD:730866 6480464 Benzo(a)pyrene affects the methylation of RGS5 intron CTD PMID:30157460 benzo[a]pyrene decreases expression ISO RGD:730866 6480464 Benzo(a)pyrene results in decreased expression of RGS5 mRNA CTD PMID:32234424 benzo[a]pyrene diol epoxide I increases expression ISO RGD:730866 6480464 7 more ... CTD PMID:20382639 bisphenol A increases expression ISO RGD:730867 6480464 bisphenol A results in increased expression of RGS5 mRNA CTD PMID:26063408 , PMID:30951980 bisphenol A increases methylation ISO RGD:730867 6480464 bisphenol A results in increased methylation of RGS5 promoter CTD PMID:27312807 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of RGS5 mRNA CTD PMID:25181051 , PMID:30816183 bisphenol F increases expression ISO RGD:730867 6480464 bisphenol F results in increased expression of RGS5 mRNA CTD PMID:30951980 butanal decreases expression ISO RGD:730866 6480464 butyraldehyde results in decreased expression of RGS5 mRNA CTD PMID:26079696 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of RGS5 mRNA CTD PMID:25993096 carbon nanotube decreases expression ISO RGD:730867 6480464 Nanotubes, Carbon analog results in decreased expression of RGS5 mRNA CTD PMID:25620056 carbon nanotube increases expression ISO RGD:730867 6480464 Nanotubes, Carbon analog results in increased expression of RGS5 mRNA, Nanotubes, Carbon results in increased expression of RGS5 mRNA CTD PMID:25554681 clorgyline increases expression ISO RGD:730866 6480464 Clorgyline results in increased expression of RGS5 mRNA CTD PMID:19691856 cobalt dichloride decreases expression ISO RGD:730866 6480464 cobaltous chloride results in decreased expression of RGS5 mRNA CTD PMID:19320972 copper atom increases expression EXP 6480464 Copper results in increased expression of RGS5 mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of RGS5 mRNA CTD PMID:30556269 crocidolite asbestos increases expression ISO RGD:730867 6480464 Asbestos, Crocidolite results in increased expression of RGS5 mRNA CTD PMID:19446018 deoxynivalenol decreases expression ISO RGD:730866 6480464 deoxynivalenol results in decreased expression of RGS5 mRNA CTD PMID:31863870 dibenz[a,h]anthracene increases expression ISO RGD:730867 6480464 1 more ... CTD PMID:26377693 dioxygen increases expression ISO RGD:730867 6480464 Oxygen deficiency results in increased expression of RGS5 mRNA CTD PMID:20880076 diuron decreases expression EXP 6480464 Diuron results in decreased expression of RGS5 mRNA CTD PMID:25152437 diuron increases expression EXP 6480464 Diuron results in increased expression of RGS5 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:730866 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:730866 6480464 Doxorubicin results in decreased expression of RGS5 mRNA CTD PMID:29803840 ellagic acid decreases expression ISO RGD:730866 6480464 Ellagic Acid results in decreased expression of RGS5 mRNA CTD PMID:12002526 entinostat multiple interactions ISO RGD:730866 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RGS5 mRNA CTD PMID:27188386 entinostat increases expression ISO RGD:730866 6480464 entinostat results in increased expression of RGS5 mRNA CTD PMID:26272509 ethanol affects expression ISO RGD:730867 6480464 Ethanol affects the expression of RGS5 mRNA CTD PMID:30319688 ethanol multiple interactions ISO RGD:730867 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of RGS5 mRNA CTD PMID:30517762 fipronil increases expression EXP 6480464 fipronil results in increased expression of RGS5 mRNA CTD PMID:23962444 , PMID:31881178 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of RGS5 mRNA CTD PMID:18035473 folic acid decreases expression ISO RGD:730867 6480464 Folic Acid results in decreased expression of RGS5 mRNA CTD PMID:25629700 furan increases expression EXP 6480464 furan results in increased expression of RGS5 mRNA CTD PMID:25539665 , PMID:26194646 glafenine increases expression EXP 6480464 Glafenine results in increased expression of RGS5 mRNA CTD PMID:24136188 hydrogen peroxide affects expression ISO RGD:730866 6480464 Hydrogen Peroxide affects the expression of RGS5 mRNA CTD PMID:21179406 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of RGS5 mRNA CTD PMID:21396975 linalool increases expression EXP 6480464 linalool results in increased expression of RGS5 mRNA CTD PMID:20536181 manganese atom decreases expression ISO RGD:730866 6480464 Manganese results in decreased expression of RGS5 mRNA CTD PMID:17175027 manganese(0) decreases expression ISO RGD:730866 6480464 Manganese results in decreased expression of RGS5 mRNA CTD PMID:17175027 manganese(II) chloride decreases expression ISO RGD:730866 6480464 manganese chloride results in decreased expression of RGS5 mRNA CTD PMID:17175027 mercury dibromide increases expression ISO RGD:730866 6480464 mercuric bromide results in increased expression of RGS5 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:730866 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RGS5 mRNA CTD PMID:27188386 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of RGS5 mRNA CTD PMID:32035215 methylmercury chloride decreases expression ISO RGD:730866 6480464 methylmercuric chloride results in decreased expression of RGS5 mRNA CTD PMID:23179753 more ... N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of RGS5 mRNA CTD PMID:25380136 nickel atom decreases expression ISO RGD:730866 6480464 Nickel results in decreased expression of RGS5 mRNA CTD PMID:24768652 , PMID:25583101 O-methyleugenol decreases expression ISO RGD:730866 6480464 methyleugenol results in decreased expression of RGS5 mRNA CTD PMID:32234424 okadaic acid affects expression ISO RGD:730866 6480464 Okadaic Acid affects the expression of RGS5 mRNA CTD PMID:22788371 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of RGS5 mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of RGS5 mRNA CTD PMID:25729387 panobinostat multiple interactions ISO RGD:730866 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RGS5 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:730866 6480464 panobinostat results in increased expression of RGS5 mRNA CTD PMID:26272509 paracetamol affects expression ISO RGD:730867 6480464 Acetaminophen affects the expression of RGS5 mRNA CTD PMID:17562736 pentachlorophenol increases expression ISO RGD:730867 6480464 Pentachlorophenol results in increased expression of RGS5 mRNA CTD PMID:23892564 pentanal decreases expression ISO RGD:730866 6480464 pentanal results in decreased expression of RGS5 mRNA CTD PMID:26079696 phenobarbital affects expression ISO RGD:730867 6480464 Phenobarbital affects the expression of RGS5 mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO RGD:730866 6480464 Phenylmercuric Acetate results in increased expression of RGS5 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:730866 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RGS5 mRNA CTD PMID:27188386 pioglitazone multiple interactions ISO RGD:730867 6480464 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of RGS5 mRNA CTD PMID:27935865 pirinixic acid decreases expression ISO RGD:730867 6480464 pirinixic acid results in decreased expression of RGS5 mRNA CTD PMID:17426115 potassium dichromate affects expression ISO RGD:730867 6480464 Potassium Dichromate affects the expression of RGS5 mRNA CTD PMID:23608068 progesterone multiple interactions ISO RGD:730866 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of RGS5 mRNA CTD PMID:17404688 progesterone decreases expression EXP 6480464 Progesterone results in decreased expression of RGS5 mRNA CTD PMID:20726854 quercetin increases expression ISO RGD:730867 6480464 Quercetin results in increased expression of RGS5 mRNA CTD PMID:16455785 quercetin increases expression ISO RGD:730866 6480464 Quercetin results in increased expression of RGS5 mRNA CTD PMID:21632981 reserpine decreases expression EXP 6480464 Reserpine results in decreased expression of RGS5 mRNA CTD PMID:14505795 resveratrol decreases expression ISO RGD:730866 6480464 resveratrol results in decreased expression of RGS5 mRNA CTD PMID:12569576 SB 431542 multiple interactions ISO RGD:730866 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:730866 6480464 Silicon Dioxide analog results in decreased expression of RGS5 mRNA CTD PMID:23806026 , PMID:25895662 silicon dioxide increases expression ISO RGD:730867 6480464 Silicon Dioxide results in increased expression of RGS5 mRNA CTD PMID:23221170 sodium arsenate increases expression ISO RGD:730867 6480464 sodium arsenate results in increased expression of RGS5 mRNA CTD PMID:21795629 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of RGS5 mRNA CTD PMID:25993096 Soman decreases expression EXP 6480464 Soman results in decreased expression of RGS5 mRNA CTD PMID:19281266 sulforaphane increases expression ISO RGD:730867 6480464 sulforafan results in increased expression of RGS5 mRNA CTD PMID:30529165 sunitinib decreases expression ISO RGD:730866 6480464 Sunitinib results in decreased expression of RGS5 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:730867 6480464 Tamoxifen affects the expression of RGS5 mRNA CTD PMID:17555576 tetrachloroethene increases expression ISO RGD:730867 6480464 Tetrachloroethylene results in increased expression of RGS5 mRNA CTD PMID:28973375 tetrachloromethane affects expression ISO RGD:730867 6480464 Carbon Tetrachloride affects the expression of RGS5 mRNA CTD PMID:17484886 tetrachloromethane multiple interactions ISO RGD:730867 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of RGS5 mRNA CTD PMID:30517762 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of RGS5 mRNA CTD PMID:31150632 thapsigargin decreases expression ISO RGD:730866 6480464 Thapsigargin results in decreased expression of RGS5 mRNA CTD PMID:22378314 toluene increases expression EXP 6480464 Toluene results in increased expression of RGS5 mRNA CTD PMID:22967744 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of RGS5 mRNA CTD PMID:25729387 trichostatin A increases expression ISO RGD:730866 6480464 trichostatin A results in increased expression of RGS5 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:730866 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RGS5 mRNA CTD PMID:27188386 triphenyl phosphate decreases expression ISO RGD:730866 6480464 triphenyl phosphate results in decreased expression of RGS5 mRNA CTD PMID:28934090 tunicamycin decreases expression ISO RGD:730866 6480464 Tunicamycin results in decreased expression of RGS5 mRNA CTD PMID:22378314 undecane increases expression EXP 6480464 undecane results in increased expression of RGS5 protein CTD PMID:17337753 valproic acid decreases expression ISO RGD:730866 6480464 Valproic Acid results in decreased expression of RGS5 mRNA CTD PMID:26272509 , PMID:29154799 valproic acid increases expression ISO RGD:730866 6480464 Valproic Acid results in increased expression of RGS5 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:730866 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RGS5 mRNA CTD PMID:27188386 vorinostat multiple interactions ISO RGD:730866 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RGS5 mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:730866 6480464 vorinostat results in increased expression of RGS5 mRNA CTD PMID:26272509
Gene-Chemical Interaction Annotations
